Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Evotec Se
(OP:
EVOTF
)
6.640
+0.070 (+1.07%)
Streaming Delayed Price
Updated: 10:32 AM EDT, Aug 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
100
Open
6.640
Bid (Size)
N/A (0)
Ask (Size)
N/A (0)
Prev. Close
6.570
Today's Range
6.640 - 6.640
52wk Range
6.570 - 24.61
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Evotec Announces Progress in Strategic Neuroscience Partnership with Bristol Myers Squibb
January 07, 2024
Via
ACCESSWIRE
Apple Loses Appeal Over 4G Patent Infringement In London Court, AI Can Drive TSMC's Revenue Rebound, Alibaba Conducts Strategic Review of Youku and Tudou Amidst Rivalry: Today's Top Stories
July 05, 2023
Reuters
Via
Benzinga
Performance
YTD
-69.37%
-69.37%
1 Month
-24.37%
-24.37%
3 Month
-26.06%
-26.06%
6 Month
-51.99%
-51.99%
1 Year
-70.09%
-70.09%
More News
Read More
Evotec Secures US Government Contract For Orthopoxvirus Antibody
July 05, 2023
Via
Benzinga
Adapsyn Bioscience Inks Collaboration Pact With Evotec
September 21, 2022
Via
Benzinga
The Daily Biotech Pulse: FDA Decision On Biogen Alzheimer's Drug Due In January, FDA Reviews Roche's Lymphoma Candidate, Rare Pediatric Tag For Kazia's Pediatric Brain Cancer Candidate
July 06, 2022
Via
Benzinga
Evotec Enters a Drug Discovery Collaboration with Janssen
June 14, 2022
From
Evotec SE
Via
AccessWire
Evotec and Almirall Enter into a Multi-Target Alliance in Medical Dermatology
May 19, 2022
From
Evotec AG
Via
AccessWire
Evotec SE Fiscal Year 2021 Results: 'Setting the Pace' on the Data-Driven R&D Autobahn to Cures
April 12, 2022
From
Evotec AG
Via
AccessWire
Evotec Achieves Programme Designation in Neuroscience Collaboration with Bristol Myers Squibb
April 08, 2022
From
Evotec AG
Via
AccessWire
Why Are Evotec Shares Trading Lower On Friday?
February 04, 2022
Via
Benzinga
Evotec Receives € 7.5 m Grant for Development of COVID-19 Therapeutic
January 03, 2022
From
Evotec AG
Via
AccessWire
Exposures
COVID-19
Germany Based Evotec Sets Terms For $576M US IPO
October 27, 2021
Via
Benzinga
Pasithea, Evotec Ink Drug Development Pact
October 11, 2021
Via
Benzinga
Evotec Expands Neuroscience Collaboration with Bristol Myers
October 08, 2021
Via
Benzinga
Bristol Myers Exercises Option In-License Evotec's Neurodegenerative Candidate
September 02, 2021
Via
Benzinga
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.